2m 2m 2m 2m 2m 2m 2m
Biogen (BIIB)
NASDAQ
$197.12-$2.94 (-1.47%)
Price as of Jun 15, 2026 7:20 PM EDT- $29.5BMarket Cap
- 53.12%1-Year Change
- Drug Manufacturers - GeneralIndustry
Biogen (BIIB)
$197.12-$2.94 (-1.47%)
Earnings Score
Valuation | BIIB | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | BIIB | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 7.38% | ||
12-Month Momentum | 54.58% | ||
3-Month Risk Adjusted Momentum | 52.71% | ||
12-Month Risk Adjusted Momentum | 171.43% |
True Yield
Valuation | BIIB | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.61% | ||
Net Debt Paydown Yield | -0.008% |
Financial Health Score
Valuation | BIIB | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 8 |